AAAAAA
Results:
1-23
|
Results: 23
Authors:
CALDERWOOD S
DOYLE JJ
ROLLANDGRINTON M
ZAFAR M
ROIFMAN C
FREEDMAN MH
SAUNDERS EF
Citation: S. Calderwood et al., WHEN ARE 2ND ALLOGENEIC BONE-MARROW TRANSPLANTS INDICATED IN PEDIATRIC-PATIENTS, International journal of pediatric hematology/oncology, 5(5), 1998, pp. 337-343
Authors:
KHATTAK S
ROGAN JW
SAUNDERS EF
THEIS JGW
ARBUS GS
KOREN G
Citation: S. Khattak et al., EFFICACY OF AMLODIPINE IN PEDIATRIC BONE-MARROW TRANSPLANT PATIENTS, Clinical pediatrics, 37(1), 1998, pp. 31-35
Authors:
PETERS C
SHAPIRO EG
ANDERSON J
HENSLEEDOWNEY PJ
KLEMPERER MR
COWAN MJ
SAUNDERS EF
DEALARCON PA
TWIST C
NACHMAN JB
HALE GA
HARRIS RE
ROZANS MK
KURTZBERG J
GRAYSON GH
WILIAMS TE
LENARSKY C
WAGNER JE
KRIVIT W
Citation: C. Peters et al., HURLER-SYNDROME - II - OUTCOME OF HLA GENOTYPICALLY IDENTICAL SIBLINGAND HLA-HAPLOIDENTICAL RELATED DONOR BONE-MARROW TRANSPLANTATION IN 54 CHILDREN, Blood, 91(7), 1998, pp. 2601-2608
Authors:
CHATTERGOON DS
SAUNDERS EF
KLEIN J
CALDERWOOD S
DOYLE J
FREEDMAN MH
KOREN G
Citation: Ds. Chattergoon et al., AN IMPROVED LIMITED SAMPLING METHOD FOR INDIVIDUALIZED BUSULFAN DOSING IN BONE-MARROW TRANSPLANTATION IN CHILDREN, Bone marrow transplantation, 20(5), 1997, pp. 347-354
Authors:
NOWACZYK MJM
SAUNDERS EF
TEIN I
BLASER SI
CLARKE JTR
Citation: Mjm. Nowaczyk et al., IMMUNOABLATION DOES NOT DELAY THE NEUROLOGIC PROGRESSION OF X-LINKED ADRENOLEUKODYSTROPHY, The Journal of pediatrics, 131(3), 1997, pp. 453-455
Authors:
CALDERWOOD S
ROLLANDGRINTON M
DOYLE JJ
FREEDMAN MH
SAUNDERS EF
Citation: S. Calderwood et al., HIGH-DOSE ETOPOSIDE AND TBI CONDITIONING FOLLOWED BY ALLOGENEIC BMT FOR HIGH-RISK PEDIATRIC ALL, Blood, 90(10), 1997, pp. 4350-4350
Authors:
CHATTERGOON DS
KOREN G
SAUNDERS EF
Citation: Ds. Chattergoon et al., BUSULFAN TABLET FORMULATION AND BUSULFAN DISPOSITION, A WORD OF CAUTION, Blood, 90(10), 1997, pp. 4352-4352
Authors:
SAXON BR
DOYLE JJ
FEIGENBAUM A
DUPUIS LL
CALDERWOOD S
FREEDMAN MH
SAUNDERS EF
Citation: Br. Saxon et al., FATAL HYPERAMMONEMIA COMPLICATING PEDIATRIC BONE-MARROW TRANSPLANTATION, Blood, 90(10), 1997, pp. 4386-4386
Authors:
FOULADI M
HERMAN R
ROLLANDGRINTON M
BLANCHETTE V
CALDERWOOD S
DOYLE JJ
LEAKER M
SAUNDERS EF
ZIPURSKY A
FREEDMAN MH
Citation: M. Fouladi et al., ACQUIRED APLASTIC-ANEMIA IN CHILDREN - COMPARISON OF OUTCOME OF BONE-MARROW TRANSPLANTATION (BMT) VERSUS IMMUNOSUPPRESSIVE THERAPY (IT) FROM 1977-1997, Blood, 90(10), 1997, pp. 1013-1013
Authors:
CALDERWOOD S
DOYLE JJ
HITZLER JK
SAUNDERS EF
FREEDMAN MH
Citation: S. Calderwood et al., ADMINISTRATION OF RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN CHILDREN WITH ACUTE MYELOGENOUS LEUKEMIA - A NOTE OF CAUTION, Bone marrow transplantation, 18(1), 1996, pp. 87-91
Authors:
KING SM
SAUNDERS EF
PETRIC M
GOLD R
Citation: Sm. King et al., RESPONSE TO MEASLES, MUMPS AND RUBELLA VACCINE IN PEDIATRIC BONE-MARROW TRANSPLANT RECIPIENTS, Bone marrow transplantation, 17(4), 1996, pp. 633-636
Authors:
BERKOVITCH M
MATSUI D
ZIPURSKY A
BLANCHETTE VS
VERJEE Z
GIESBRECHT E
SAUNDERS EF
EVANS WE
KOREN G
Citation: M. Berkovitch et al., HEPATOTOXICITY OF 6-MERCAPTOPURINE IN CHILDHOOD ACUTE LYMPHOCYTIC-LEUKEMIA - PHARMACOKINETIC CHARACTERISTICS, Medical and pediatric oncology, 26(2), 1996, pp. 85-89
Authors:
SAXON BR
DOYLE J
FREEDMAN M
SAUNDERS EF
CALDERWOOD S
Citation: Br. Saxon et al., COMPARISON BETWEEN MELPHALAN AND BUSULFAN CYCLOPHOSPHAMIDE CONDITIONING FOR AUTOLOGOUS BMT IN PEDIATRIC AML/, Blood, 88(10), 1996, pp. 495-495
Authors:
CALDERWOOD S
ROLLANDGRINTON M
DOYLE JJ
FREEDMAN MH
SAUNDERS EF
Citation: S. Calderwood et al., OUTCOME FOLLOWING 2ND ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) INPEDIATRIC-PATIENTS, Blood, 88(10), 1996, pp. 2448-2448
Authors:
CHATTERGOON DS
CALDERWOOD S
DOYLE J
FREEDMAN MH
KOREN G
SAUNDERS EF
Citation: Ds. Chattergoon et al., TOXICITY AND ENGRAFTMENT AFTER INDIVIDUALIZED BUSULFAN (BU) DOSING INBONE-MARROW TRANSPLANTATION (BMT) IN CHILDREN - INTERIM RESULTS, Blood, 86(10), 1995, pp. 862-862
Authors:
CHATTERGOON DS
KOREN G
SAUNDERS EF
Citation: Ds. Chattergoon et al., A COMPARISON OF LIMITED SAMPLING METHODS (LSMS) FOR ESTIMATION OF BUSULFAN (BU) AREA-UNDER-THE-CURVE (AUC) IN CHILDREN UNDERGOING BONE-MARROW TRANSPLANTATION (BMT), Blood, 86(10), 1995, pp. 2256-2256
Authors:
CALDERWOOD S
SAUNDERS EF
DOYLE JJ
FREEDMAN MH
POON A
ROCK G
Citation: S. Calderwood et al., PERIPHERAL-BLOOD STEM-CELL (PBSC) COLLECTION AND TRANSPLANTATION IN THE MANAGEMENT OF CHILDHOOD-CANCER, Blood, 86(10), 1995, pp. 3747-3747
Authors:
CHATTERGOON DS
KOREN G
SAUNDERS EF
Citation: Ds. Chattergoon et al., DEVELOPMENT OF A LIMITED SAMPLING METHOD (LSM) FOR CALCULATION OF AREA-UNDER-THE-CURVE (AUC) OF CONCENTRATION OF BUSULFAN (BU) VS TIME IN CHILDREN UNDERGOING BONE-MARROW TRANSPLANTATION (BMT), Blood, 86(10), 1995, pp. 3750-3750
Authors:
HITZLER JK
DOYLE J
SAUNDERS EF
ROLLANDGRINTON M
FREEDMAN MH
CALDERWOOD S
Citation: Jk. Hitzler et al., SURVIVAL AND LENGTH OF HOSPITALIZATION AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR AML IN CHILDREN RECEIVING GM-CSF - A NOTE OF CAUTION, Blood, 84(10), 1994, pp. 10000091-10000091
Authors:
CHAN A
ROLLANDGRINTON M
DOYLE J
FREEDMAN MH
SAUNDERS EF
CALDERWOOD S
Citation: A. Chan et al., EFFECT OF RHGM-CSF ON OUTCOME OF ALLOGENEIC BONE-MARROW TRANSPLANTATION IN PEDIATRIC-PATIENTS - A RETROSPECTIVE ANALYSIS, Blood, 84(10), 1994, pp. 10000705-10000705
Authors:
SAUNDERS EF
CALDERWOOD S
FREEDMAN MH
DOYLE J
Citation: Ef. Saunders et al., UNRELATED DONOR BONE-MARROW TRANSPLANTATION IN CHILDREN, Blood, 84(10), 1994, pp. 10000720-10000720
Authors:
SAUNDERS EF
OLIVIERI N
FREEDMAN MH
Citation: Ef. Saunders et al., UNEXPECTED COMPLICATIONS AFTER BONE-MARROW TRANSPLANTATION IN TRANSFUSION-DEPENDENT CHILDREN, Bone marrow transplantation, 12, 1993, pp. 88-90
Authors:
ALHASHMI I
WANG H
SAUNDERS EF
ZIPURSKY A
FREEDMAN MH
Citation: I. Alhashmi et al., G-CSF THERAPY, CONGENITAL NEUTROPENIA AND THE DEVELOPMENT OF MYELODYSPLASTIC SYNDROME WITH MONOSOMY-7, Blood, 82(10), 1993, pp. 10000551-10000551
Risultati:
1-23
|